Guess’ Inc. (NYSE:GES) shares moved up 1.39% in last trading session and ended the day at $22.54. GES Gross Margin is 36.10% and its has a return on assets of 5.90%. Guess’ Inc. (NYSE:GES) quarterly performance is 29.82%.

Guess?, Inc. (GUESS?) designs, markets, distributes and licenses a collection of apparel and accessories for men, women and children. GUESS? operates through five segments: North American Retail, Europe, Asia, North American Wholesale and Licensing. The North American Retail segment includes the Company’s retail and e-commerce operations in North America, and its retail operations in Central and South America.

UPDATED: See Today’s Top 50 Trending Stocks

Guess’ Inc. (NYSE:GES) reported quarterly net earnings of $18.3 million, or $0.21 per share, compared to $22.0 million, or $0.26 per share, for the year-ago quarter. Its total net revenue dropped 10.2 percent to $546.3 million from $608.6 million. However, analysts were expecting earnings of $0.15 per share on revenue of $537.61 million.

Unitil Corp. (NYSE:UTL) ended the last trading day at $36.33. Company weekly volatility is calculated as 2.90% and price to cash ratio as 31.55. Unitil Corp. (NYSE:UTL) showed a weekly performance of -2.13%.

Unitil Corporation (Unitil) is a public utility holding company. The Company is engaged in the distribution of electricity and natural gas. The Company operates in three segments: utility gas operations, utility electric operations and non-regulated. The Company’s principal business is the local distribution of electricity in the southeastern seacoast and state capitol regions of New Hampshire and the greater Fitchburg area of north central Massachusetts and the local distribution of natural gas in southeastern New Hampshire, portions of southern Maine to the Lewiston-Auburn area and in the greater Fitchburg area of north central Massachusetts.

Zacks upgraded shares of Unitil (NYSE:UTL) from a hold rating to a buy rating in a research report sent to investors on Monday morning, MarketBeat.Com reports. The firm currently has $40.00 price target on the stock.

On 28 August, Grupo Financiero Galicia S.A. (NASDAQ:GGAL) shares moved down -0.81% and was closed at $19.56. GGAL EPS growth in last 5 year was 32.90%. Grupo Financiero Galicia S.A. (NASDAQ:GGAL) year to date (YTD) performance is 23.59%.

Grupo Financiero Galicia S.A. (Grupo Financiero Galicia) is a financial services holding company. Banco de Galicia y Buenos Aires S.A. (Banco Galicia) is the Company’s largest subsidiary. Banco Galicia is a bank that provides, directly or through its subsidiaries, a range of financial products and services to large corporations, small and medium sized companies (SMEs), and individuals.

AbbVie Inc. (NYSE:ABBV) shares moved down -0.82% in last trading session and ended the day at $63.98. ABBV Gross Margin is 80.70% and its has a return on assets of 6.10%. AbbVie Inc. (NYSE:ABBV) quarterly performance is -3.70%.

AbbVie Inc. (AbbVie) is a global, research-based biopharmaceutical company. The Company develops and markets therapies that address a range of diseases. The Company’s products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn’s disease; hepatitis C (HCV); human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinson’s disease; complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone

On 19 August, it was reported AbbVie Inc (NYSE:ABBV) has bought a priority review voucher from United Therapeutics Corp for $350 million that will allow it to accelerate the review process for one of its drugs.

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) caters to the Healthcare space. Its weekly performance is 12.81%. On the last day of trading company shares ended up $4.14. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) distance from 50-day simple moving average (SMA50) is -6.94%.

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), announced that executives from the company will present at Rodman Renshaw’s 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 10:25am ET/7:25am PT at the St. Regis Hotel in New York City by Pedro Lichtinger, Chief Executive Officer.

Comments

Leave a Reply

You must be logged in to post a comment.